JPS5759815A - Drug composition having preventing and remedying action on rotavirus infectious disease - Google Patents

Drug composition having preventing and remedying action on rotavirus infectious disease

Info

Publication number
JPS5759815A
JPS5759815A JP13626880A JP13626880A JPS5759815A JP S5759815 A JPS5759815 A JP S5759815A JP 13626880 A JP13626880 A JP 13626880A JP 13626880 A JP13626880 A JP 13626880A JP S5759815 A JPS5759815 A JP S5759815A
Authority
JP
Japan
Prior art keywords
rotavirus
preventing
iga
monomer
monomer iga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13626880A
Other languages
Japanese (ja)
Other versions
JPS6355494B2 (en
Inventor
Yoshitomo Fujii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Priority to JP13626880A priority Critical patent/JPS5759815A/en
Publication of JPS5759815A publication Critical patent/JPS5759815A/en
Publication of JPS6355494B2 publication Critical patent/JPS6355494B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE: A preventive and remedy for a rotavirus infections diesease, having neutralizing activity on rotavirus and high safety, comprising a monomer IgA as a main ingredient.
CONSTITUTION: An immunoglobulin comprising a monomer IgA as a main ingredient is collected from the serum, plasma, and placental blood of humal and mammals as a raw material, and used for preventing and remedying rotavirus. The raw material is purified by salting out method, ion exchange chromatography, gel filtration, affinity chromatography, etc., so that the content of IgG causing allergic reactions like anaphylaxis is ≤10wt%, preferably a mall amount as less as possible. The obtained monomer IgA exhibits strong neutralizing acrivity against rotavirus, and also suppresses the propagation of rotarirus in an animal experiment. In pharmaceutical preparation, after being converted into a common oral drug, it is advantageously subjected to enteric coating. The dosage is 10W5,000mg/day as monomer IgA.
COPYRIGHT: (C)1982,JPO&Japio
JP13626880A 1980-09-30 1980-09-30 Drug composition having preventing and remedying action on rotavirus infectious disease Granted JPS5759815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP13626880A JPS5759815A (en) 1980-09-30 1980-09-30 Drug composition having preventing and remedying action on rotavirus infectious disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13626880A JPS5759815A (en) 1980-09-30 1980-09-30 Drug composition having preventing and remedying action on rotavirus infectious disease

Publications (2)

Publication Number Publication Date
JPS5759815A true JPS5759815A (en) 1982-04-10
JPS6355494B2 JPS6355494B2 (en) 1988-11-02

Family

ID=15171210

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13626880A Granted JPS5759815A (en) 1980-09-30 1980-09-30 Drug composition having preventing and remedying action on rotavirus infectious disease

Country Status (1)

Country Link
JP (1) JPS5759815A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57185222A (en) * 1981-05-01 1982-11-15 Cutter Lab Oral immunogloblin
WO1995022350A1 (en) * 1994-02-18 1995-08-24 Immuno Aktiengesellschaft Composition and method for preventing and treating inflammation with immunoglobulin a
EP0692491A1 (en) 1994-07-14 1996-01-17 IMMUNO Aktiengesellschaft Human virus-free monomeric immunoglobulin A and method for its production
EP1267928A2 (en) * 2000-03-27 2003-01-02 Medarex, Inc. Methods for immunostimulation using bispecific binding agents for the fc receptor of immunoglobulin a and for cancer cells or infectious antigen
US6646108B1 (en) 1996-01-12 2003-11-11 Baxter Aktiengesellschaft Process for isolating IgG and IgA

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139617A (en) * 1975-05-29 1976-12-02 Green Cross Corp:The A process for preparing a remedy for intestinal infectious diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139617A (en) * 1975-05-29 1976-12-02 Green Cross Corp:The A process for preparing a remedy for intestinal infectious diseases

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57185222A (en) * 1981-05-01 1982-11-15 Cutter Lab Oral immunogloblin
WO1995022350A1 (en) * 1994-02-18 1995-08-24 Immuno Aktiengesellschaft Composition and method for preventing and treating inflammation with immunoglobulin a
US5833984A (en) * 1994-02-18 1998-11-10 Immuno Aktiengesellschaft Composition and method for preventing and treating inflammation with Immunoglobulin A
EP0692491A1 (en) 1994-07-14 1996-01-17 IMMUNO Aktiengesellschaft Human virus-free monomeric immunoglobulin A and method for its production
DE4424935C1 (en) * 1994-07-14 1996-03-21 Immuno Ag Human virus-safe monomeric immunoglobulin A and process for its preparation
US5808000A (en) * 1994-07-14 1998-09-15 Immuno Aktiengesellschaft Virus-safe monomeric human immunoglobulin A and methods for its production
US6646108B1 (en) 1996-01-12 2003-11-11 Baxter Aktiengesellschaft Process for isolating IgG and IgA
EP1267928A2 (en) * 2000-03-27 2003-01-02 Medarex, Inc. Methods for immunostimulation using bispecific binding agents for the fc receptor of immunoglobulin a and for cancer cells or infectious antigen

Also Published As

Publication number Publication date
JPS6355494B2 (en) 1988-11-02

Similar Documents

Publication Publication Date Title
WO1996013512A3 (en) L-ribofuranosyl nucleosides
EP0168830B1 (en) Immunoglobulin preparation in combination with another pharmacologically active preparation for use in the treatment of diseases
AR240251A1 (en) METHOD TO PREPARE A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS AND A METHOD TO SYNTHESIZE 3 'AZIDO 2', 3 'DIDEOXIURIDINA INTENDED FOR THE PREPARATION OF SUCH COMPOSITION.
PT80079B (en) PROCESS FOR THE PREPARATION OF ANTI-VIRUS PHARMACEUTICAL COMPOSITIONS CONTAINING 2-DIETILAMINO-2 ', 6'-ACETOXYLID (LIDOCAINE)
DE3377063D1 (en) Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
CA2092905A1 (en) Treatment of autoimmune diseases by oral administration of autoantigens
FR2504408B1 (en) PROCESS FOR THE PREPARATION OF SUBMICROSCOPIC PARTICLES, PARTICLES THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE25246T1 (en) TRIPHENYLIMIDAZOLYLOXYALKANOIC ACIDS AND THEIR DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
EP0046909B1 (en) Pharmaceutical composition
SE8405615L (en) PHARMACEUTICAL TABLES WITH DEPAVERATION AND PROCEDURE FOR THEIR PREPARATION
AU1082988A (en) 5-hydroxy-3-aminochroman compounds, processes for their preparation, pharmaceutical compositions containing them and methods of treatment therewith
DE69521536D1 (en) Compositions containing G-CSF and a TNF binding protein
JPS5759815A (en) Drug composition having preventing and remedying action on rotavirus infectious disease
FR2553409B1 (en) NOVEL BENZENESULFONYL-LACTAMES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ACTIVE SUBSTANCE OF PHARMACEUTICAL COMPOSITIONS
WO1996013498A3 (en) L-erythrosyl nucleosides
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
HUP9802431A2 (en) Pharmaceutical compns. contg. pentosan polysulfate for the treatment of chronic progressive vascular diseases
FR2507605B1 (en) PROCESS FOR THE PREPARATION OF APOVINCAMINIC ACID ESTERS, ESTERS THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS PREPARED THEREWITH
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
WO2000025754A3 (en) Solid oral dosage forms containing alginic acid and famotidine
DE3169890D1 (en) Derivative of n-acetilcysteine having therapeutical activity, process for its preparation and related pharmaceutical compositions
IE870577L (en) Topical amide preparation
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
AU591017B2 (en) Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient